Literature DB >> 19668264

Senescence and p130/Rbl2: a new beginning to the end.

Francesco P Fiorentino1, Catherine E Symonds, Marcella Macaluso, Antonio Giordano.   

Abstract

Senescence is the process of cellular aging dependent on the normal physiological functions of non-immortalized cells. With increasing data being uncovered in this field, the complex molecular web regulating senescence is gradually being unraveled. Recent studies have suggested two main phases of senescence, the triggering of senescence and the maintenance of senescence. Each has been supported by data implying precise roles for DNA methyltransferases, reactive oxygen species and other factors. We will first summarize the data supporting these claims and then highlight the specific role that we hypothesize that p130/Rbl2 plays in the modulation of the senescence process.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19668264     DOI: 10.1038/cr.2009.96

Source DB:  PubMed          Journal:  Cell Res        ISSN: 1001-0602            Impact factor:   25.617


  12 in total

1.  LPS-induced inflammatory response triggers cell cycle reactivation in murine neuronal cells through retinoblastoma proteins induction.

Authors:  Barbara D'Angelo; Carlo Astarita; Silvia Boffo; Mina Massaro-Giordano; Carmelina Antonella Ianuzzi; Antonella Caporaso; Marcella Macaluso; Antonio Giordano
Journal:  Cell Cycle       Date:  2017       Impact factor: 4.534

2.  Growth suppression by MYC inhibition in small cell lung cancer cells with TP53 and RB1 inactivation.

Authors:  Francesco Paolo Fiorentino; Elvan Tokgün; Sònia Solé-Sánchez; Sabrina Giampaolo; Onur Tokgün; Toni Jauset; Takashi Kohno; Manuel Perucho; Laura Soucek; Jun Yokota
Journal:  Oncotarget       Date:  2016-05-24

3.  The role of genetic breast cancer susceptibility variants as prognostic factors.

Authors:  Peter A Fasching; Paul D P Pharoah; Angela Cox; Heli Nevanlinna; Stig E Bojesen; Thomas Karn; Annegien Broeks; Flora E van Leeuwen; Laura J van't Veer; Renate Udo; Alison M Dunning; Dario Greco; Kristiina Aittomäki; Carl Blomqvist; Mitul Shah; Børge G Nordestgaard; Henrik Flyger; John L Hopper; Melissa C Southey; Carmel Apicella; Montserrat Garcia-Closas; Mark Sherman; Jolanta Lissowska; Caroline Seynaeve; Petra E A Huijts; Rob A E M Tollenaar; Argyrios Ziogas; Arif B Ekici; Claudia Rauh; Arto Mannermaa; Vesa Kataja; Veli-Matti Kosma; Jaana M Hartikainen; Irene L Andrulis; Hilmi Ozcelik; Anna-Marie Mulligan; Gord Glendon; Per Hall; Kamila Czene; Jianjun Liu; Jenny Chang-Claude; Shan Wang-Gohrke; Ursula Eilber; Stefan Nickels; Thilo Dörk; Maria Schiekel; Michael Bremer; Tjoung-Won Park-Simon; Graham G Giles; Gianluca Severi; Laura Baglietto; Maartje J Hooning; John W M Martens; Agnes Jager; Mieke Kriege; Annika Lindblom; Sara Margolin; Fergus J Couch; Kristen N Stevens; Janet E Olson; Matthew Kosel; Simon S Cross; Sabapathy P Balasubramanian; Malcolm W R Reed; Alexander Miron; Esther M John; Robert Winqvist; Katri Pylkäs; Arja Jukkola-Vuorinen; Saila Kauppila; Barbara Burwinkel; Frederik Marme; Andreas Schneeweiss; Christof Sohn; Georgia Chenevix-Trench; Diether Lambrechts; Anne-Sophie Dieudonne; Sigrid Hatse; Erik van Limbergen; Javier Benitez; Roger L Milne; M Pilar Zamora; José Ignacio Arias Pérez; Bernardo Bonanni; Bernard Peissel; Bernard Loris; Paolo Peterlongo; Preetha Rajaraman; Sara J Schonfeld; Hoda Anton-Culver; Peter Devilee; Matthias W Beckmann; Dennis J Slamon; Kelly-Anne Phillips; Jonine D Figueroa; Manjeet K Humphreys; Douglas F Easton; Marjanka K Schmidt
Journal:  Hum Mol Genet       Date:  2012-04-24       Impact factor: 6.150

4.  RBL2 bi-allelic truncating variants cause severe motor and cognitive impairment without evidence for abnormalities in DNA methylation or telomeric function.

Authors:  Sara Selig; Karin Weiss; Nadra Samra; Shir Toubiana; Hilde Yttervik; Aya Tzur-Gilat; Ilham Morani; Chen Itzkovich; Liran Giladi; Kamal Abu Jabal; John Z Cao; Lucy A Godley; Adi Mory; Hagit Baris Feldman; Kristian Tveten
Journal:  J Hum Genet       Date:  2021-05-13       Impact factor: 3.172

5.  In vitro phosphorylation and acetylation of the murine pocket protein Rb2/p130.

Authors:  Muhammad Saeed; Florian Schwarze; Adele Loidl; Joachim Meraner; Markus Lechner; Peter Loidl
Journal:  PLoS One       Date:  2012-09-24       Impact factor: 3.240

6.  The role of p21 in regulating mammalian regeneration.

Authors:  Larry Matthew Arthur; Ellen Heber-Katz
Journal:  Stem Cell Res Ther       Date:  2011-06-29       Impact factor: 6.832

7.  Glucose Transporter 1 Promotes the Malignant Phenotype of Non-Small Cell Lung Cancer through Integrin β1/Src/FAK Signaling.

Authors:  Huanyu Zhao; Jian Sun; Jianshuang Shao; Zifang Zou; Xueshan Qiu; Enhua Wang; Guangping Wu
Journal:  J Cancer       Date:  2019-08-27       Impact factor: 4.207

8.  SATB1 collaborates with loss of p16 in cellular transformation.

Authors:  R Agrelo; H Kishimoto; M Novatchkova; V Peraza; M Paolino; A Souabni; A Wutz
Journal:  Oncogene       Date:  2013-05-20       Impact factor: 9.867

9.  Cell senescence in myxoid/round cell liposarcoma.

Authors:  Christina Kåbjörn Gustafsson; Anders Ståhlberg; Katarina Engtröm; Anna Danielsson; Ingela Turesson; Pierre Aman
Journal:  Sarcoma       Date:  2014-06-24

10.  Targeted Gene Expression Profile Reveals CDK4 as Therapeutic Target for Selected Patients With Adrenocortical Carcinoma.

Authors:  Raimunde Liang; Isabel Weigand; Juliane Lippert; Stefan Kircher; Barbara Altieri; Sonja Steinhauer; Constanze Hantel; Simone Rost; Andreas Rosenwald; Matthias Kroiss; Martin Fassnacht; Silviu Sbiera; Cristina L Ronchi
Journal:  Front Endocrinol (Lausanne)       Date:  2020-04-16       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.